Cargando…
Made to Measure: Patient-Tailored Treatment of Multiple Sclerosis Using Cell-Based Therapies
Currently, there is still no cure for multiple sclerosis (MS), which is an autoimmune and neurodegenerative disease of the central nervous system. Treatment options predominantly consist of drugs that affect adaptive immunity and lead to a reduction of the inflammatory disease activity. A broad rang...
Autores principales: | Wens, Inez, Janssens, Ibo, Derdelinckx, Judith, Meena, Megha, Willekens, Barbara, Cools, Nathalie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8304207/ https://www.ncbi.nlm.nih.gov/pubmed/34299154 http://dx.doi.org/10.3390/ijms22147536 |
Ejemplares similares
-
Cells to the Rescue: Emerging Cell-Based Treatment Approaches for NMOSD and MOGAD
por: Derdelinckx, Judith, et al.
Publicado: (2021) -
Neurotrophic Factors as Regenerative Therapy for Neurodegenerative Diseases: Current Status, Challenges and Future Perspectives
por: El Ouaamari, Yousra, et al.
Publicado: (2023) -
Beyond the Magic Bullet: Current Progress of Therapeutic Vaccination in Multiple Sclerosis
por: Willekens, Barbara, et al.
Publicado: (2018) -
On the road to new treatments for multiple sclerosis: targeting dendritic cell migration into the central nervous system
por: Meena, Megha, et al.
Publicado: (2019) -
HLA Class II Genotype Does Not Affect the Myelin Responsiveness of Multiple Sclerosis Patients
por: Derdelinckx, Judith, et al.
Publicado: (2020)